# A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee

> **NCT02847702** · PHASE2 · TERMINATED · sponsor: **Purdue Pharma LP** · enrollment: 75 (actual)

## Conditions studied

- Osteoarthritis Pain of the Knee

## Interventions

- **DRUG:** VM902A 200-mg Capsules
- **DRUG:** VM902A 400-mg Capsules
- **DRUG:** Naproxen 500-mg Capsules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02847702
- **Lead sponsor:** Purdue Pharma LP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08
- **Primary completion:** 2016-11-22
- **Final completion:** 2016-11-22
- **Target enrollment:** 75 (ACTUAL)
- **Why stopped:** Company decision
- **Last updated:** 2017-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02847702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02847702, "A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02847702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*